Current Events

General Motors Co. is recalling more than 27,000 Cadillac SUVs worldwide because the wheels can fall off.

The company says the recall affects the 2013 Cadillac SRX with 18-inch wheels. Canadian safety regulators say the wheel nuts may not have been tightened enough at the factory.

Click here to read more.

The Center for Auto Safety is asking top officials at the Chrysler Group and its parent company, Fiat, to recall about five million vehicles. The nonprofit consumer advocacy group said, “Children are dying in Jeeps in rear-impact fires.”

In a letter to John Elkann on Wednesday, Fiat’s chairman, the center cited the deaths of three children since 2006 in fires that occurred when the Jeeps in which they were riding were struck from the rear.

Click here to read more.

Subaru is recalling a relative handful of 2013 Outback and Legacy models for a potentially huge issue that the automaker thought it had fixed last year -- the steering could fail.

Affected: 5,379 Outback and Legacy models made Feb.15, 2012 through June 15, 2012. No injuries or deaths are reported.

Subaru lists the supplier of the potentially defective shafts as NSK Steering Systems America, of Bennington, Vermont.

Click here to read more.

The Food and Drug Administration has been interviewing doctors in a review of complaints about a popular robotic surgery device.

In a prepared statement, FDA spokeswoman Synim Rivers said the survey was undertaken after an increase in the number of complaints received about the da Vinci surgical system. Sunnyvale Calif.-based Intuitive Surgical Inc. makes the robots, which are used in gynecological, kidney and general surgery.

Click here to read more.

The Wall Street Journal recently published the results of a study by researchers at Johns Hopkins who found that diagnostic errors accounted for a major and costly portion of the overall medical errors that take place in the U.S. each year.

The study, published in the journal BMJ Quality and Safety, involved researchers examining 350,000 medical malpractice claims that have been filed over the past 25 years. The results were clear that the most common, most expensive and, ultimately, the most dangerous errors were in misdiagnosing patients. The study estimated that such misdiagnosis leads to permanent injury or death in as many as 160,000 people each year.

Click here to read more.

The orthopedic unit of Johnson & Johnson said Thursday that it was phasing out production of all-metal replacement hips, a move reflecting an industrywide trend to abandon the once widely used implants because of high early failure rates.

In 2010, the company, DePuy Orthopaedics, recalled an all-metal model known as the Articular Surface Replacement, or A.S.R., because it was failing just a few years after implant. Typically, artificial hips made from materials like plastic and metal last 15 years or more before they wear out and need to be replaced.

Click here to read more.

The Food and Drug Administration approved label changes incorporating lower dosages for sleep medications containing zolpidem, a drug that can continue to affect patients' mental alertness even a day after its use.

The regulator approved changes to the labels of Sanofi SA's Ambien, Ambien CR and Meda AB's Edluar on Tuesday.

Click here to read more.

Subaru is recalling 5,379 Legacy and Outback cars in the United States because of a problem that could cause them to lose steering control.

Steering shafts in the cars, all from the 2013 model year, could become disengaged, causing a loss of steering. The steering shaft on the cars is made from two pieces -- an inner and an outer shaft -- which, in the vehicles involved, can become separated. If that happens, the driver can lose the ability to steer the car.

Click here to read more.

GlaxoSmithKline Plc (GSK)’s Avandia, the best-selling diabetes pill that was pulled off the market in Europe and tightly restricted in the U.S. because of its heart risks, will undergo another regulatory review.

The U.S. Food and Drug Administration plans a June meeting to discuss a re-analysis of a 2009 study, known as Record, that found Avandia more than doubled the risk of heart failure, without increasing hospital stays or death from cardiovascular disease. The re-analysis was requested by a previous advisory panel that found the drug should remain available in the U.S.

Click here to read more.

Federal inspectors have found dozens of potentially dangerous safety problems at 30 specialized pharmacies, months after tainted steroid shots made by a Massachusetts pharmacy triggered the worst drug disaster in decades.

At a Florida company, Food and Drug Administration inspectors discovered “black particles of unknown origin” in seven vials of an injectable medicine. At other facilities, they found rust and mold in “clean rooms,” inadequate microbial testing and tears in gloves worn by technicians — lapses that raise the risk of possible lethal contamination.

Click here to read more.

Analysis of commercially available rice imported into the US has revealed it contains levels of lead far higher than regulations suggest are safe.

Some samples exceeded the "provisional total tolerable intake" (PTTI) set by the US Food and Drug Administration (FDA) by a factor of 120.

The report at the American Chemical Society Meeting adds to the already well-known issue of arsenic in rice.

The FDA told the BBC it would review the research.

Lead is known to be harmful to many organs and the central nervous system.

Click here to read more.